The treatment of Bursitis & Fibrocystic Breast Disease with vitamins

Bursitis and Fibrocystic Breast Disease: Mitamins custom make quality formulas for the treatment of Bursitis & Fibrocystic Breast Disease with vitamins. A Bursitis & Fibrocystic Breast Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Bursitis and Fibrocystic Breast Disease

  • Amount Per Serving
    % DV
    Vitamin C
    800
    mg
    1333%
    Vitamin E
    200
    IU
    667%
    Vitamin B6
    50
    mg
    2500%
    Magnesium
    100
    mg
    25%
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    100
    mg
    *
    Turmeric Extract
    300
    mg
    *
    Bromelain
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Bursitis and Fibrocystic Breast Disease
Serving Size:4-5

Bursitis and Fibrocystic Breast Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Drug Cuts NSAID Users' Risk Of Hospitalization For Peptic Ulcer By More Than Half
People who also take a drug called a 'proton pump inhibitor" to reduce stomach acid when regularly using aspirin, ibuprofen, or another traditional non-steroidal anti-inflammatory drug (NSAID) for pain relief from arthritis or other conditions, cut their odds of eventually being hospitalized for an ulcer by 54 percent, according to a new study sponsored by HHS' Agency for Healthcare Research and Quality.
PTC Therapeutics Announces Encouraging Additional Phase 2 Results Of PTC124 In Cystic Fibrosis
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, today announced encouraging data from a Phase 2 clinical trial of PTC124 in pediatric patients with cystic fibrosis (CF) due to a nonsense mutation.
This information concerning the support of Bursitis and Fibrocystic Breast Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments